Scholarly Index
Robert A. Figlin
Cedars-Sinai Medical Center; 51,951 total citations; 580 total publications; best world rank #11
Cedars-Sinai Medical Center
51,951Total citations
580Total publications
106H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Renal cell carcinoma treatment | Lifetime | 11 | US 9 | 99.87 |
| Renal and related cancers | Lifetime | 17 | US 15 | 99.79 |
| Cancer Genomics and Diagnostics | Lifetime | 73 | US 45 | 99.79 |
| Cancer Immunotherapy and Biomarkers | Lifetime | 160 | US 94 | 99.59 |
| Economic and Financial Impacts of Cancer | Lifetime | 39 | US 30 | 99.21 |
| Bladder and Urothelial Cancer Treatments | Lifetime | 125 | US 79 | 99.36 |
| Ferroptosis and cancer prognosis | Lifetime | 338 | US 97 | 96.22 |
| PI3K/AKT/mTOR signaling in cancer | Lifetime | 295 | US 180 | 97.59 |
| Cancer Research and Treatments | Lifetime | 666 | US 361 | 96.84 |
| Multiple and Secondary Primary Cancers | Lifetime | 338 | US 144 | 96.67 |
| Tuberous Sclerosis Complex Research | Lifetime | 274 | US 154 | 90.39 |
| Renal cell carcinoma treatment | 2021-2025 | 491 | US 175 | 93.01 |
| Renal and related cancers | 2021-2025 | 487 | US 192 | 87.70 |